Literature DB >> 11743309

Pain and morbidity of an extensive prostate 10-biopsy protocol: a prospective study in 289 patients.

Michael Peyromaure1, Vincent Ravery, Aurel Messas, Marianne Toublanc, Lilianne Boccon-Gibod, Laurent Boccon-Gibod.   

Abstract

PURPOSE: Some studies imply that increasing the number of prostate biopsy cores may improve the cancer detection rate. We performed a prospective study to evaluate pain and morbidity after an extensive transrectal ultrasound guided 10-core biopsy protocol.
MATERIALS AND METHODS: A total of 289 consecutive men with abnormal digital rectal examination findings and/or increased prostate specific antigen underwent extensive prostate biopsy involving 6 sextant and 4 peripheral biopsies. Each received an information leaflet a few days before the procedure. A single dose of fluoroquinolone and a rectal enema were administered before biopsy. In no case was the procedure performed using anesthesia. Immediately after biopsy patients were asked to complete a self-administered nonvalidated questionnaire evaluating the degree of pain and/or discomfort using a visual analog scale. In another questionnaire they listed the side effects noticed during month 1 after biopsy.
RESULTS: Although 48% of the 275 men who completed the initial questionnaire reported anxiety before the procedure, 78.8% of them were completely reassured by the information brochure. Of the 275 patients 47.6% described the procedure as painful, including only slightly painful (analog visual scale 3 or less) in 67.9%, while 33.8% described it as uncomfortable but not painful and 18.6% thought that it was neither painful nor uncomfortable. Of the 115 patients who engaged in sexual intercourse during month 1 after the procedure 78.3% noticed hematospermia an average of 10.9 days in duration. Of the 164 men who completed questionnaire 2, 74.4% noticed hematuria an average of 2.7 days in duration, 3.7% noticed pyrexia and 1.2% noticed acute prostatitis. In the 59 patients (36%) who reported delayed perineal pain it was slight in 64.4%, moderate in 30.5% and severe in 5.1%. No patient required hospitalization.
CONCLUSIONS: Although minor complications are common, the extensive 10-core prostate biopsy protocol is associated with few major complications. The occurrence and intensity of pain and discomfort are in the range reported after the standard 6-core biopsy protocol.

Entities:  

Mesh:

Year:  2002        PMID: 11743309

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  20 in total

1.  Time of administration of a single dose of oral levofloxacin and its effect in infectious complications from transrectal prostate biopsy.

Authors:  Athanasios N Argyropoulos; Konstantinos Doumas; Antonios Farmakis; Ioannis Liakatas; Ioannis Gkialas; Michael Lykourinas
Journal:  Int Urol Nephrol       Date:  2007-01-04       Impact factor: 2.370

2.  Comparison of two different doses of lidocaine on the pain sensation during transrectal ultrasound-guided prostate biopsy.

Authors:  Ferhat Ateş; Furkan Dursun; Ercan Malkoç; Ömer Yılmaz; Hasan Soydan; Hüseyin Şen; Şeref Başal; Fatih Zekey; Kenan Karademir
Journal:  Turk J Urol       Date:  2016-09

3.  Is endorectal coil necessary for the staging of clinically localized prostate cancer? Comparison of non-endorectal versus endorectal MR imaging.

Authors:  Seung Hwan Lee; Kyung Kgi Park; Kyung Hwa Choi; Beom Jin Lim; Joo Hee Kim; Seung Wook Lee; Byung Ha Chung
Journal:  World J Urol       Date:  2010-07-11       Impact factor: 4.226

4.  MRI-guided core needle biopsy of the prostate: acceptance and side effects.

Authors:  Nina Egbers; Carsten Schwenke; Andreas Maxeiner; Ulf Teichgräber; Tobias Franiel
Journal:  Diagn Interv Radiol       Date:  2015 May-Jun       Impact factor: 2.630

5.  Is quadrant biopsy sufficient in men likely to have advanced prostate cancer? Comparison with extended biopsy.

Authors:  Zoran Brnic; Slavko Gasparov; Petar Vladislav Lozo; Petar Anic; Leonardo Patrlj; Vesna Ramljak
Journal:  Pathol Oncol Res       Date:  2005-03-31       Impact factor: 3.201

6.  The effect of ultrasound-guided compression immediately after transrectal ultrasound-guided prostate biopsy on postbiopsy bleeding: a randomized controlled pilot study.

Authors:  Bong Hee Park; Jung Im Kim; Sang Rak Bae; Yong Seok Lee; Sung Hak Kang; Chang Hee Han
Journal:  Int Urol Nephrol       Date:  2017-05-04       Impact factor: 2.370

7.  Early growth response 1 and fatty acid synthase expression is altered in tumor adjacent prostate tissue and indicates field cancerization.

Authors:  Anna C Jones; Kristina A Trujillo; Genevieve K Phillips; Trisha M Fleet; Jaclyn K Murton; Virginia Severns; Satyan K Shah; Michael S Davis; Anthony Y Smith; Jeffrey K Griffith; Edgar G Fischer; Marco Bisoffi
Journal:  Prostate       Date:  2011-11-29       Impact factor: 4.104

8.  MR-guided transgluteal biopsies with an open low-field system in patients with clinically suspected prostate cancer: technique and preliminary results.

Authors:  Stephan Zangos; Katrin Eichler; Kerstin Engelmann; Mukhtiar Ahmed; Sebastian Dettmer; Christopher Herzog; Wasilios Pegios; A Wetter; Thomas Lehnert; Martin G Mack; Thomas J Vogl
Journal:  Eur Radiol       Date:  2004-09-04       Impact factor: 5.315

9.  Complications of transrectal ultrasound-guided 12-core prostate biopsy: a single center experience with 2049 patients.

Authors:  Ozan Efesoy; Murat Bozlu; Selahittin Çayan; Erdem Akbay
Journal:  Turk J Urol       Date:  2013-03

10.  Urinary TMPRSS2:ERG and PCA3 in an active surveillance cohort: results from a baseline analysis in the Canary Prostate Active Surveillance Study.

Authors:  Daniel W Lin; Lisa F Newcomb; Elissa C Brown; James D Brooks; Peter R Carroll; Ziding Feng; Martin E Gleave; Raymond S Lance; Martin G Sanda; Ian M Thompson; John T Wei; Peter S Nelson
Journal:  Clin Cancer Res       Date:  2013-03-20       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.